Curis (CRIS) Reports Q3 Loss, Tops Revenue Estimates

Curis (CRIS) came out with a quarterly loss of $1.70 per share versus the Zacks Consensus Estimate of a loss of $1.88. This compares to loss of $2.13 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.57%. A quarter ago, it was expected that this drug developer would post a loss of $1.70 per share when it actually produced a loss of $2.03, delivering a surprise of -19.41%.Over the last four quarters, the company has surpassed c ...